In August 2015 the French Anti-Doping Agency (AFLD) reported an anti-doping rule violation against the Athlete after her sample tested positive for the prohibited substances Prednisolone and Prednisone. Following notification the Athlete filed a statement in her defence.
The Athlete admitted the violation and denied the intentional use of the substances. She explained with evidence that she underwent medical treatment for her Asthma and that she had used Solupred tablets (Prednisone) prescribed by her doctor.
The AFLD determines that:
- The Athlete committed an anti-doping rule violation;
- She underwent legitimate medical treatment for her condition;
- There was a medical justification for the prescribed substance;
- Her use of the prescribed medication was consistent with the concentration found in her sample;
Therefore the AFLD decides on 3 February 2016 for the acquittal of the Athlete.
